Literature DB >> 11073569

Fatty acid transport proteins facilitate fatty acid uptake in skeletal muscle.

J J Luiken1, J F Glatz, A Bonen.   

Abstract

In view of the importance of long chain fatty acids (LCFAs) to many cellular processes, it may be desirable to regulate the LCFA disposition in the cell. Such regulation may be present at the level of the plasma membrane, since a number of putative LCFA transport proteins have been cloned. The development of a model system of giant vesicles has proven to be important in identifying the metabolic role of the LCFA transport system. LCFA transport rates and transporters (FABPpm and FAT/CD36) are scaled with oxidative capacity of heart and muscle. FAT/CD36 is a critical LCFA transport protein in muscle. With chronic contraction the increase in this protein also results in an increase in LCFA transport. Most importantly, LCFA transport is also increased acutely by muscle contraction, involving the translocation of FAT/CD36 from intracellular depots to the surface of the muscle cell. The acute (minutes) and chronic (days) regulation of LCFA transporters and transport by muscle may be an important mechanism for LCFA utilization during exercise and adaptable with training and with a metabolic disease such as type 2 diabetes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11073569

Source DB:  PubMed          Journal:  Can J Appl Physiol        ISSN: 1066-7814


  10 in total

Review 1.  Critical steps in cellular fatty acid uptake and utilization.

Authors:  Ger J van der Vusse; Marc van Bilsen; Jan F C Glatz; Danny M Hasselbaink; Joost J F P Luiken
Journal:  Mol Cell Biochem       Date:  2002-10       Impact factor: 3.396

2.  Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice.

Authors:  Tuoyu Geng; Lili Xia; Sarah Russo; Davida Kamara; Lauren Ashley Cowart
Journal:  Nutr Res       Date:  2015-07-02       Impact factor: 3.315

Review 3.  Regulatable fatty acid transport mechanisms are central to the pathophysiology of obesity, fatty liver, and metabolic syndrome.

Authors:  Paul D Berk
Journal:  Hepatology       Date:  2008-11       Impact factor: 17.425

4.  Commentary on fatty acid wars: the diffusionists versus the translocatists.

Authors:  Henry Pownall; Kathryn Moore
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-03-20       Impact factor: 8.311

5.  Commentary on SSO and other putative inhibitors of FA transport across membranes by CD36 disrupt intracellular metabolism, but do not affect fatty acid translocation.

Authors:  Henry J Pownall
Journal:  J Lipid Res       Date:  2020-03-20       Impact factor: 5.922

6.  The role of hyperglycemia in FAT/CD36 expression and function.

Authors:  Min Chen; Ying-Kui Yang; Tara J Loux; Keith E Georgeson; Carroll M Harmon
Journal:  Pediatr Surg Int       Date:  2006-07-13       Impact factor: 1.827

7.  Exercise training in rats impairs the replenishment of white adipose tissue after partial lipectomy.

Authors:  Carlos A Habitante; Lila M Oyama; Allain Amador Bueno; Eliane Beraldi Ribeiro; Débora Estadella; Ana R Dâmaso; Claudia M Oller do Nascimento
Journal:  Eur J Appl Physiol       Date:  2010-01-30       Impact factor: 3.078

Review 8.  Nonalcoholic Fatty Liver Disease: Lipids and Insulin Resistance.

Authors:  Paul D Berk; Elizabeth C Verna
Journal:  Clin Liver Dis       Date:  2016-02-18       Impact factor: 6.126

9.  Adipocyte accumulation of long-chain fatty acids in obesity is multifactorial, resulting from increased fatty acid uptake and decreased activity of genes involved in fat utilization.

Authors:  José L Walewski; Fengxia Ge; Michel Gagner; William B Inabnet; Alfons Pomp; Andrea D Branch; Paul D Berk
Journal:  Obes Surg       Date:  2009-10-29       Impact factor: 4.129

10.  Effects of cAMP modulators on long-chain fatty-acid uptake and utilization by electrically stimulated rat cardiac myocytes.

Authors:  J J F P Luiken; J Willems; S L M Coort; W A Coumans; A Bonen; G J Van Der Vusse; J F C Glatz
Journal:  Biochem J       Date:  2002-11-01       Impact factor: 3.857

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.